Robert Orlowski, M.D., Ph.D., of the MD Anderson Cancer Center shared early results from the LINKER-MM1 trial with Managed Healthcare Executive, which is testing linvoseltamab in people newly ...

He also discussed how linvoseltamab could fit into care for newly diagnosed patients. With several treatment options already available, he said linvoseltamab may become another strong choice, ...

Researchers said future studies could help refine the use of Jaypirca alone or in combination with other therapies as a frontline treatment. She added that they are also continuing to investigate ...

Each Sunday we feature a highlight reel of various articles posted on our website that week.

Venclexta-azacitidine combination offered better responses with less hospitalization and lower symptom burden compared with ...